Note: Ingredients listed on restricted chemical lists
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
1-5
General Information
Revision date
2014-12-01
Product name
RoofPro
Product name
RoofPro
Identification on the label/Trade name
Roll Roofing
Manufacturer Name
GAF
Icons in SDS
Company Information
company name
GAF
Section 2
SECTION 2: Hazards identification
Principle Routes of Exposure
SIGNS & SYMPTOMS OF EXPOSURE EYES Occasional nuisance dust, Inhalation May cause irritation to the eyes. SKIN May cause irritation to the skin. INGESTION This product is not intended to be ingested. If ingested, it may cause temporary irritation to the gastrointestinal (digestive) tract. INHALATION May cause irritation to the respiratory tract.
Acute Health Hazards
NIOSH has found that studies of workers exposed to asphalt fumes have repeatedly found irritation of the serous membranes of the conjunctivae (eye irritation) and the mucous membranes of the upper respiratory tract (nasal and throat irritation).
Health hazards
Studies in humans have found that exposure to respirable crystalline silica (quartz) can cause silicosis, a fibrosis (scarring) of the lungs. Silicosis is a serious and irreversible disease; it may be progressive even after exposure has ceased; it can lead to disability and death. Human studies also have found that silicosis is a risk factor for tuberculosis, and that occupational exposure to respirable crystalline silica is associated with chronic obstructive pulmonary disease, including bronchitis and emphysema. Some studies show excess numbers of cases of scleroderma, connective tissue disorders, lupus, rheumatoid arthritis, chronic kidney diseases and end-stage kidney disease in workers exposed to respirable crystalline silica. CARCINOGENICITY NIOSH has concluded that the collective data from human, animal, genotoxicity and exposure studies provide sufficient evidence that roofing asphalt fumes are a potential occupational carcinogen. Occupational exposure to respirable crystalline silica is classified as a known carcinogen in humans. IARC has determined that respirable crystalline silica is carcinogenic to humans (Group 1), based on findings of sufficient evidence of carcinogenicity in both humans and experimental animals. NTP has classified respirable crystalline silica as a known human carcinogen based on sufficient evidence of carcinogenicity from studies in humans indicating a causal relationship between occupational exposure to respirable crystalline silica and increased lung cancer rates. NIOSH has determined that respirable crystalline silica is a potential occupational carcinogen.